Skip to content
Recall Observatory FDA recall evidence

Drug product

Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.

D-0462-2022

January 05, 2022

Class I

Product summary

Firm
Mylan Pharmaceuticals Inc
Event
Event 89357
Status
Terminated
Classification
Class I
Quantity
73,175 prefilled pens
Official record key
drug-enforcement:D-0462-2022

Official wording

Reason: Labeling: Missing Label: label missing from some Semglee prefilled pens.

Code information: Batch # BF20003118, Exp. August 2022

Distribution pattern: Nationwide in the USA and Thailand.

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Missing Label: label missing